Le Lézard
Classified in: Health
Subjects: NPT, VET, DIS

Wounded Warrior Project: Blood Tests to Treat PTSD


WASHINGTON, Feb. 21, 2018 /PRNewswire-USNewswire/ -- It is estimated 500,000 of this generation of wounded veterans live with the symptoms of post-traumatic stress disorder (PTSD). Another 320,000 suffered a traumatic brain injury (TBI). There are few proven methods to diagnose and treat the signature wounds of the wars in Afghanistan and Iraq. Not every veteran living with these ailments responds the same to specific treatment.

Wounded Warrior Project VP of Mental Health Programs and Independence Services Michael Richardson joined Cohen Veterans Bioscience CEO and President Dr. Magali Haas to announce blood tests to better target treatment for PTSD and TBI.

To help, Wounded Warrior Project® (WWP) is working with Cohen Veterans Bioscience (CVB) to identify and study biomarkers that could improve treatment options. A biomarker is a measurable substance indicative of a disease or infection. For veterans, a specific biomarker found in a blood sample can confirm a PTSD diagnosis and the potential to respond to treatment.

By studying these substances, researchers hope to better target PTSD treatment in veterans and other trauma survivors.

"We would love to cure PTSD and TBI one day," said Mike Richardson, WWP vice president of mental health and independence services. "Until then, we will continue to target treatment and do what is best for the veterans we serve."

As part of this support Wounded Warrior Project's Warrior Care Network® will be actively involved in the research into biomarkers ? testing wounded veterans and helping identify the most effective treatment options. Warrior Care Network (woundedwarriorproject.org/programs/warrior-care-network) is an innovative partnership with four top facilities focused on providing world-class mental health care to wounded veterans. While the treatment shows clinically proven results, more can still be done.

"We value Wounded Warrior Project's collaboration and support to help advance a first generation of PTSD & TBI diagnostics," said Magali Haas, MD, PhD, CVB's CEO & President.  "We need an all-hands approach to tackle this important scientific & clinical challenge."

This collaboration can advance a roadmap for discovery, replication, and qualification of biomarkers ? an effort that can create solutions in years, not decades.

About Wounded Warrior Project
Wounded Warrior Project® (WWP) connects, serves, and empowers wounded warriors. Read more at http://newsroom.woundedwarriorproject.org/about-us.

About Cohen Veterans Bioscience 
Cohen Veterans Bioscience is a national, nonpartisan research organization dedicated to fast-tracking the development of diagnostic tests and personalized therapeutics for the millions of veterans and civilians who suffer the devastating effects of trauma-related and other brain disorders. To support & learn more about our research efforts, visit www.cohenveteransbioscience.org.

SOURCE Wounded Warrior Project


These press releases may also interest you

25 avr 2024
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...

25 avr 2024
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

25 avr 2024
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

25 avr 2024
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

25 avr 2024
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...

25 avr 2024
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...



News published on and distributed by: